These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3488924)

  • 21. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 22. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2).
    Jürgenliemk-Schulz IM; Renes IB; Rutgers DH; Everse LA; Bernsen MR; Den Otter W; Battermann JJ
    Radiat Oncol Investig; 1997; 5(2):54-61. PubMed ID: 9303058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapy of malignant tumors with subpopulations of T lymphocytes].
    Fernández-Cruz E
    Rev Esp Oncol; 1982; 29(4):701-10. PubMed ID: 6242320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2].
    Mir LM; Roth C; Orlowski S; Belehradek J; Fradelizi D; Paoletti C; Kourilsky P
    C R Acad Sci III; 1992; 314(12):539-44. PubMed ID: 1381659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
    Kedar E; Chriqui-Zeira E; Kyriazis AP
    J Biol Response Mod; 1984 Oct; 3(5):517-26. PubMed ID: 6334139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas.
    Niwa O; Kamiya K; Furihata C; Nitta Y; Wang Z; Fan YJ; Ninomiya Y; Kotomura N; Numoto M; Kominami R
    Cancer Res; 1995 Dec; 55(23):5670-6. PubMed ID: 7585652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour inhibitory effects of TCGF/IL-2/-containing preparations.
    Bubeník J; Indrová M; Perlmann P; Berzins K; Mach O; Kraml J; Toulcová A
    Cancer Immunol Immunother; 1985; 19(1):57-61. PubMed ID: 3872165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.
    Forni G; Giovarelli M; Santoni A
    J Immunol; 1985 Feb; 134(2):1305-11. PubMed ID: 3871210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of modified tumor antigen on experimentally induced sarcomas.
    Nigam SK; Bhatt VH
    Saudi Med J; 2001 Feb; 22(2):157-63. PubMed ID: 11299413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
    Berman RM; Suzuki T; Tahara H; Robbins PD; Narula SK; Lotze MT
    J Immunol; 1996 Jul; 157(1):231-8. PubMed ID: 8683120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prophylactic and therapeutic administration of BCG vaccine on growth of experimental sarcoma.
    Símová J; Bubeník J
    Folia Biol (Praha); 1975; 21(5):329-33. PubMed ID: 172377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancare-a herbal formulation inhibits chemically induced tumours in experimental animals.
    Rajeshkumar NV; Kuttan R
    Indian J Exp Biol; 2001 Jul; 39(7):654-9. PubMed ID: 12019758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
    Fernandez-Cruz E; Gilman SC; Feldman JD
    J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ; Simon RM; Baker AR
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell lines.
    Staab HJ; Anderer FA
    Cancer Detect Prev; 1984; 7(4):279-88. PubMed ID: 6091881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.